Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RARE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
RARE
Ultragenyx Pharmaceutical Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
RARE
Ultragenyx Pharmaceutical Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
RARE
Ultragenyx Pharmaceutical Inc.
Change
16.63
▲
+2.01%
· post 15.90
Mkt cap
$1.6B
Revenue
$214M
Q2 FY26
Revenue
$673M
FY25
LLY
ELI Lilly & Co
Change
1,407.25
▼
−0.27%
· post 1,416.42
Closed
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 3 '26
RARE
Ultragenyx Pharmaceutical Inc.
vs
LLY
ELI Lilly & Co
16.63
▲
+2.01%
post 15.90
Price
1,407.25
▼
−0.27%
post 1,416.42
$1.6B
Mkt cap
$1.3T
Q2 FY26
$214M
Revenue
$24.4B
Q3 FY26
FY25
$673M
Revenue
$65.2B
FY25
Change
Change
RARE
16.63
▲
+2.01%
vs
LLY
1,407.25
▼
−0.27%
Closed
Nov 3 '26
Co-movers
daily closes
Method
›
Moved together
RARE
with
LLY
No shared trading history for RARE and LLY.
Shared co-movers: not yet measured (RARE).
RARE, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes